Efficacy and tolerability of MAP0004, a novel orally inhaled therapy, in treating acute migraine

被引：0
|
作者：
Silberstein, S. D. [1 ]
Kori, S. H. [2 ]
Tepper, S. J. [3 ]
Borland, S. W. [2 ]
Wang, M. [2 ]
Reppine, A. E. [2 ]
Armer, T. A. [2 ]
Dodick, D. W. [4 ]
机构：
[1] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA
[2] MAP Pharmaceut Inc, Mountain View, CA USA
[3] Cleveland Clin, Neurol Ctr Pain, Cleveland, OH 44106 USA
[4] Mayo Clin, Scottsdale, AZ USA
来源：
CEPHALALGIA | 2009年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：12 / 13
页数：2
相关论文
共 50 条
  • [1] Efficacy and tolerability of MAP0004, featuring a movel delivery system, in treating acute migraine
    Shrewsbury, Stephen
    Kori, Shashidhar
    Smith, Timothy
    Spierings, Egilius
    NEUROLOGY, 2008, 70 (11) : A426 - A426
  • [2] MAP0004, Orally Inhaled Dihydroergotamine for Acute Treatment of Migraine: Efficacy of Early and Late Treatments
    Tepper, Stewart J.
    Kori, Shashidhar H.
    Goadsby, Peter J.
    Winner, Paul K.
    Wang, Min H.
    Silberstein, Stephen D.
    Cutrer, F. Michael
    MAYO CLINIC PROCEEDINGS, 2011, 86 (10) : 948 - 955
  • [3] Efficacy of MAP0004 in treating severe migraine
    Kori, S.
    Connors, E.
    Zhou, J.
    Lu, B.
    Borland, S.
    JOURNAL OF HEADACHE AND PAIN, 2013, 14
  • [4] Efficacy of MAP0004 in treating severe migraine
    S Kori
    E Connors
    J Zhou
    B Lu
    S Borland
    The Journal of Headache and Pain, 2013, 14
  • [5] Efficacy and Safety of MAP0004, Orally Inhaled DHE in Treating Migraines With and Without Allodynia
    Tepper, Stewart J.
    Kori, Shashidhar H.
    Borland, Scott W.
    Wang, Min H.
    Hu, Bin
    Mathew, Ninan T.
    Silberstein, Stephen D.
    HEADACHE, 2012, 52 (01): : 37 - 47
  • [6] Evaluation of Safety and Efficacy of MAP0004 in Treating Acute Menstrual Migraine
    Schreiber, Curt
    Kori, Shashidhar H.
    Lucas, Sylvia
    Borland, Scott W.
    Wang, Min
    Hu, Bin
    Brandes, Jan
    NEUROLOGY, 2010, 74 (09) : A396 - A396
  • [7] Efficacy of MAP0004 in Treating Severe Migraine Pain
    Kori, Shashidhar
    Connors, Emilee
    Zhou, Jay
    Lu, Biao
    Borland, Scott
    NEUROLOGY, 2013, 80
  • [8] MAP0004, Orally Inhaled DHE: A Randomized, Controlled Study in the Acute Treatment of Migraine
    Aurora, Sheena K.
    Silberstein, Stephen D.
    Kori, Shashidhar H.
    Tepper, Stewart J.
    Borland, Scott W.
    Wang, Min
    Dodick, David W.
    HEADACHE, 2011, 51 (04): : 507 - 517
  • [9] Evaluation of safety and efficacy of levadex™ (MAP0004) in treating acute menstrual migraine
    Kori, S.
    Schreiber, C.
    Lucas, S.
    Borland, S.
    Wang, M.
    Hu, B.
    Brandes, J.
    JOURNAL OF HEADACHE AND PAIN, 2010, 11 : S116 - S116
  • [10] Comparable Efficacy and Safety Among Patients with and Without Aura: Orally Inhaled Dihydroergotamine (MAP0004) for the Acute Treatment of Migraine
    Winner, P.
    Holdbrook, F.
    Davar, G.
    HEADACHE, 2014, 54 : 14 - 15
12345